We are live on
!
Find out more
PM
Parametrica Management Portfolio holdings
AUM
$128M
1-Year Est. Return
171.01%
This Fund
S&P 500
This Quarter
Est. Return
-10.6%
1 Year Est. Return
+171.01%
3 Year Est. Return
+584.07%
5 Year Est. Return
+696.69%
10 Year Est. Return
–
AUM
$135M
AUM Growth
+$34.3M
(+34%)
Cap. Flow
+$49.1M
Cap. Flow
% of AUM
36.36%
Top 10 Holdings %
Top 10 Hldgs %
33.16%
Holding
256
New
198
Increased
7
Reduced
21
Closed
26
Avg Time Held
0.6
quarters
Top 10 Avg Time Held
2
quarters
Top 20 Avg Time Held
1.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$7.01M |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$3.73M |
| 3 |
Li Auto
LI
|
+$3.38M |
| 4 |
Advanced Micro Devices
AMD
|
+$2.48M |
| 5 |
Hertz
HTZ
|
+$2.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Airlines
UAL
|
+$4.52M |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.71M |
| 3 |
NVIDIA
NVDA
|
+$3.19M |
| 4 |
JetBlue
JBLU
|
+$3.12M |
| 5 |
Norwegian Cruise Line
NCLH
|
+$3.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.67% |
| 2 | Technology | 17.49% |
| 3 | Communication Services | 14.87% |
| 4 | Consumer Discretionary | 13.6% |
| 5 | Industrials | 11.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
ACI Worldwide
ACIW
$5.17B
| $252K | 0.19% |
+7,996
| New | +$267K |
2022 Q1
0 quarters
|
|
152
DELISTED
2seventy bio
TSVT
| $252K | 0.19% |
14,766
| – | – |
2021 Q4
1 quarter
|
|
153
TG Therapeutics
TGTX
$8.32B
| $251K | 0.19% |
+26,402
| New | +$306K |
2022 Q1
0 quarters
|
|
154
United Rentals
URI
$66B
| $246K | 0.18% |
+692
| New | +$226K |
2022 Q1
0 quarters
|
|
155
First Majestic Silver
AG
$8.05B
| $242K | 0.18% |
+18,355
| New | +$215K |
2022 Q1
0 quarters
|
|
156
Churchill Downs
CHDN
$5.65B
| $242K | 0.18% |
+2,180
| New | +$240K |
2022 Q1
0 quarters
|
|
157
Synchrony
SYF
$23.9B
| $242K | 0.18% |
6,959
-46,371
| -87% | -$1.94M |
2020 Q2
7 quarters
|
|
158
Jabil
JBL
$33.3B
| $241K | 0.18% |
+3,912
| New | +$241K |
2022 Q1
0 quarters
|
|
159
Maravai LifeSciences
MRVI
$973M
| $241K | 0.18% |
+6,835
| New | +$229K |
2022 Q1
0 quarters
|
|
160
Truist Financial
TFC
$56.1B
| $239K | 0.18% |
+4,217
| New | +$260K |
2022 Q1
0 quarters
|
|
161
CRISPR Therapeutics
CRSP
$4.84B
| $238K | 0.18% |
+3,784
| New | +$238K |
2022 Q1
0 quarters
|
|
162
Arista Networks
ANET
$258B
| $237K | 0.18% |
+6,828
| New | +$216K |
2022 Q1
0 quarters
|
|
163
Century Communities
CCS
$1.58B
| $236K | 0.17% |
+4,413
| New | +$283K |
2022 Q1
0 quarters
|
|
164
Bath & Body Works
BBWI
$3.63B
| $235K | 0.17% |
+4,914
| New | +$265K |
2022 Q1
0 quarters
|
|
165
TE Connectivity
TEL
$62.5B
| $235K | 0.17% |
+1,796
| New | +$257K |
2022 Q1
0 quarters
|
|
166
Himax Technologies
HIMX
$2.21B
| $233K | 0.17% |
+21,495
| New | +$245K |
2022 Q1
0 quarters
|
|
167
Petrobras
PBR
$164B
| $232K | 0.17% |
+15,679
| New | +$210K |
2022 Q1
0 quarters
|
|
168
Silicon Motion
SIMO
$8.36B
| $232K | 0.17% |
+3,471
| New | +$270K |
2022 Q1
0 quarters
|
|
169
Herbalife
HLF
$1.49B
| $231K | 0.17% |
+7,606
| New | +$297K |
2022 Q1
0 quarters
|
|
170
BP
BP
$125B
| $230K | 0.17% |
+7,821
| New | +$238K |
2022 Q1
0 quarters
|
|
171
Palo Alto Networks
PANW
$325B
| $230K | 0.17% |
+2,214
| New | +$198K |
2022 Q1
0 quarters
|
|
172
Dynatrace
DT
$18.6B
| $228K | 0.17% |
+4,837
| New | +$228K |
2022 Q1
0 quarters
|
|
173
eBay
EBAY
$51.8B
| $228K | 0.17% |
+3,984
| New | +$232K |
2022 Q1
0 quarters
|
|
174
Target
TGT
$69B
| $228K | 0.17% |
+1,073
| New | +$232K |
2022 Q1
0 quarters
|
|
175
KeyCorp
KEY
$21.2B
| $227K | 0.17% |
+10,144
| New | +$252K |
2022 Q1
0 quarters
|
|
Similar funds
CIS
CWM
FCU
TLM
RPG
SIA
OCM
FFG
Parametrica Management's Q1 2022 Portfolio in Review
As of Q1 2022, Parametrica Management held 256 positions worth $135M, up 34% from $101M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Parametrica Management deployed $49.1M of net new capital in Q1 2022, opening 198 new positions and adding to 7 existing holdings. Its largest new stake was Pfizer: 135,115 shares worth $7M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 17% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $3.71M trimmed.
- Parametrica Management's largest Q1 2022 buy was Pfizer: 135,115 shares worth $7M.
- Parametrica Management added most to Alphabet (Google) Class A in Q1 2022, an estimated $1.78M increase.
- Parametrica Management's biggest Q1 2022 reduction was Meta Platforms (Facebook), cutting an estimated $3.71M.
- Parametrica Management fully exited United Airlines in Q1 2022, selling an estimated $4.52M.
- Parametrica Management's ten largest holdings make up 33% of its $135M portfolio in Q1 2022.
- Parametrica Management opened 198 new positions and closed 26 in Q1 2022.
- Parametrica Management's portfolio value rose 34% quarter-over-quarter to $135M.
Based on Parametrica Management's 13F filing for Q1 2022, filed 10 May 2022.